Two large Congresses that we do not attend but are rapidly changing our knowledge and treatment of patients with Urological Cancer. Two colleague Urologists are presenting us with the most important data that have emerged and that are highly useful for our daily practice.

Functional Urology covers the biggest part of our practice in the office, and the new data on the field can be of great help. The same goes for the news regarding men trying to conceive or cope with difficulties in their sex lives.

One of the first things we learn to do in Urology. But do we actually learn how to do it properly? There are frequently problems. Yet, there are manipulations that can help us resolve the problem.

Hormone therapy has been here for decades and the problem of intolerance to the treatment is diachronic. The solution is obviously not asking for the patient's “patience” –something that we usually rely on. But do we actually know what to do?

Articles published during the last 12 months demonstrating that technology is changing data in Endourology. How far are we from the day when prostate and prostate stones will be treated on a one-day clinic basis? And what new is there to use tomorrow in our office?

Significant progress has been made in renal cancer over the past decade, but was then lost sight of. And yet there are data and, above all, the experience to make clinical decisions. A series of cases will take us on a journey to new knowledge.

A difficult case that puzzles us. He is a young man, interested in both his survival and quality of life. The metastatic burden is limited, but still inclusive to describe metatastic cancer. Are there really only 2 bone metastases? Does that really matter in how to differentiate the treatment?

In the previous years we had been dealing with a shortage of BCG. Although this problem has been resolved, very often patients do not respond to treatment. What do we do then?